Framework agreement for the supply of a range of batch manufactured, aseptically prepared, anticancer cytotoxic chemotherapy medicines in ready to administer presentations. 10.4.2012 to 9.4.2014 with further options to extend by 2 x 12 month periods. All organisations eligible to utilise this framework agreement are detailed within documentation available through EU supply.